Blog Post

CFTR Modulator Therapies

Here’s what you need to know about the three CFTR (cystic fibrosis transmembrane conductance regulator) modulators, ivacaftor (Kalydeco®), lumacaftor/ivacaftor (Orkambi®), and tezacaftor/ivacaftor (Symdeko™).

Learn More

Did You Know?

Approximately 1,000 new cases of cystic fibrosis are diagnosed each year.

Share with friends

Topic

Reproductive Health and Fertility

Men and women with CF can have biological kids, but reproductive health and fertility have not always been priorities of CF care. As people with CF live longer, healthier lives than before, more men and women must make crucial decisions about their reproductive health.

Learn More

Blog Post

Find Out What Therapies We Are Researching for People With Rare and Nonsense Mutations

Although 90-95 percent of people with cystic fibrosis are expected to benefit from CF transmembrane regulator (CFTR) modulators, 5 percent of the population will still need alternative therapies to address the underlying cause of their disease. Learn more about the research that the Cystic Fibrosis Foundation is doing to find treatments for the 5 percent of people with these rare and nonsense mutations.

Learn More

Blog Post

Sign Up for Advocacy Action Alerts

Want to learn more about CF advocacy? Sign up to receive our emails and action alerts.

Learn More

Call us at 1 (800) FIGHT CF

or: 1 (800)-344-4823

Have a question? We can help!

Find a care center near you